Intravesical electromotive administration of oxybutynin in patients with detrusor hyperreflexia unresponsive to standard anticholinergic regimens

Journal of Urology

Volumn 165, Issue 2, 2001, Pages 491-498

  Di Stasi, Savino M ^a   Giannantoni, Antonella ^b   Vespasiani, Giuseppe ^b   Navarra, Pierluigi ^b   Capelli, Giovanni ^b   Massoud, Renato ^b   Stephen, Robert L ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b NONE

Author keywords

Abnormal; Administration; Cholinergic antagonists; Intravesical; Reflex

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; OXYBUTYNIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOAVAILABILITY; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DIFFUSION; DRUG DISTRIBUTION; FEMALE; HUMAN; HYPERREFLEXIA; MALE; PRIORITY JOURNAL; SIDE EFFECT; URINALYSIS; URODYNAMICS;

EID: 0035187804     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005392-200102000-00032     Document Type: Article

References (20)

1. Long-term urologic management of patients with spinal cord injury
2. Intravesical application of oxybutynin: Mode of action in controlling detrusor hyperreflexia
3. Intravesical oxybutynin for spinal cord injury patients
4. Relaxation of intestinal bladders by intravesical oxybutynin chloride
5. Bladder and urethral anaesthesia with electromotive drug administration (electromotive): A technique for invasive endoscopic procedures
6. Electromotive administration of oxybutynin into the human bladder wall
7. The international standards booklet for neurological and functional classification of spinal cord injury
8. The standardization of terminology in neurogenic lower urinary tract dysfunction with suggestion for diagnostic procedures
9. Estimation of the Box correction for degrees of freedom from sample data in randomized block and split-plot designs
10. Comparison of oxybutynin and its active metabolite, N-desethyl-oxybutynin, in the human detrusor and parotid gland
11. Oxybutynin: A musculotropic antispasmodic drug with moderate anticholinergic action
12. Measurement ,of oxybutynin and its N-desethyl metabolite in plasma, and its application to pharmacokinetic studies in young, elderly and frail elderly volunteers
13. Intravesical oxybutynin for neurogenic bladder dysfunction: Less systemic side effects due to reduced first pass metabolism
14. Topical oxybutynin chloride for relaxation of dysfunctional bladders
15. The use of intravesical oxybutynin chloride in children with neurogenic bladder
16. The pharmacokinetics of intravesical and oral oxybutynin chloride
17. Pharmacokinetics and effects of intravesical oxybutynin on the paediatric neurogenic bladder
18. Complications of intravesical oxybutynin chloride therapy in the pediatric myelomeningocele population
19. Mechanisms underlying the recovery of urinary bladder function following spinal cord injury
20. Intravesical lignocaine and detrusor instability